CRA consultants Ann Baker, Matthew Majewski, and Andrew Parece provide insight on various life sciences innovation topics including breaking barriers and creating value. Their comments appear in the April 2016 Celebrating Innovation special issue of PharmaVOICE. To read more, click the link below.
Low-priced oncology disruptors: The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Novel oncologic drugs continue to command premium pricing, driven by a combination of unmet needs, and delivering often-iterative, sometimes-significant...